title: Importance of measuring glycosylated hemoglobin in patients with myocardial infarction and known diabetes mellitus.
abstract: Although medical co-morbidities commonly affect clinical outcomes after acute myocardial infarction (AMI), current performance measures of AMI quality focus exclusively on the management of the AMI itself. However, patients with AMIs frequently present with other co-morbidities, such as diabetes mellitus (DM), that also warrant assessment and management. To date, the quality of DM evaluation in patients presenting with AMIs has not been described. From January 2003 to June 2004, the Prospective Registry Evaluating Myocardial Infarction Patients: Events and Recovery-Quality Improvement (PREMIER-QI) enrolled 3,953 patients with AMIs at 19 centers in the United States. The frequency of glycosylated hemoglobin (HbA(1c)) assessment, either during the hospitalization or documented in the chart from the preceding 3 months, was prospectively evaluated. Among 1,168 patients with AMIs with preexisting DM, only 47% had recent HbA(1c) levels available, with marked variability in HbA(1c) assessment among hospitals (range 7% to 81%). Among those with available HbA(1c) levels, 39% had good control (HbA(1c) <7%), 36% had suboptimal control (HbA(1c) 7% to 9%), and 25% had poor control (HbA(1c) >9%). Patients with suboptimal and poor control were more likely to have their DM treatment intensified than those without HbA(1c) assessment (for HbA(1c) 7% to 9%, rate ratio 1.38, 95% confidence interval 1.03 to 1.85; for HbA(1c) >9%, rate ratio 2.20, 95% confidence interval 1.68 to 2.88). Similarly, patients with DM who had HbA(1c) measured were more likely to receive instructions on DM disease management before discharge. In conclusion, the assessment of chronic glycemic control is highly variable among patients with AMIs and DM. Because much of this variability occurs at the hospital level, the evaluation of DM control could represent an additional quality indicator and an opportunity to advance patient-centered AMI care.
authors.affiliation: St. Luke's Mid America Heart Institute, Kansas City, Missouri, USA. jstolker@yahoo.com
authors.forename: Joshua M
authors.initials: JM
authors.lastname: Stolker
authors.forename: Dazhong
authors.initials: D
authors.lastname: Sun
authors.forename: Darcy G
authors.initials: DG
authors.lastname: Conaway
authors.forename: Philip G
authors.initials: PG
authors.lastname: Jones
authors.forename: Frederick A
authors.initials: FA
authors.lastname: Masoudi
authors.forename: Pamela N
authors.initials: PN
authors.lastname: Peterson
authors.forename: Harlan M
authors.initials: HM
authors.lastname: Krumholz
authors.forename: Mikhail
authors.initials: M
authors.lastname: Kosiborod
authors.forename: John A
authors.initials: JA
authors.lastname: Spertus
mesh_terms: D000368:Aged; D001786:Blood Glucose / Q000378:metabolism; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000150:complications* / Q000453:epidemiology; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000150:complications* / Q000453:epidemiology; D005260:Female; D005500:Follow-Up Studies; D006442:Glycated Hemoglobin / Q000378:metabolism*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000097:blood* / Q000150:complications / Q000453:epidemiology; D015995:Prevalence; D011446:Prospective Studies; D012307:Risk Factors; D015996:Survival Rate / Q000639:trends; D014481:United States / Q000453:epidemiology
chemical_list: D001786:Blood Glucose; D006442:Glycated Hemoglobin
references.citation: Ann Intern Med. 2001 Nov 6;135(9):825-34
references.pmid: 11694107
references.citation: N Engl J Med. 2005 Dec 22;353(25):2643-53
references.pmid: 16371630
references.citation: Chest. 2005 Nov;128(5):3641-51
references.pmid: 16304326
references.citation: Am Heart J. 2006 Mar;151(3):589-97
references.pmid: 16504619
references.citation: Diabetes Care. 2005 Jan;28 Suppl 1:S4-S36
references.pmid: 15618112
references.citation: N Engl J Med. 2008 Jun 12;358(24):2545-59
references.pmid: 18539917
references.citation: Diabetes Care. 2008 Jan;31 Suppl 1:S12-54
references.pmid: 18165335
references.citation: J Gen Intern Med. 2007 Aug;22(8):1206-11
references.pmid: 17516106
references.citation: N Engl J Med. 2008 Jun 12;358(24):2560-72
references.pmid: 18539916
references.citation: Arch Intern Med. 2004 May 10;164(9):982-8
references.pmid: 15136307
references.citation: Eur Heart J. 2005 Apr;26(7):650-61
references.pmid: 15728645
references.citation: Ann Intern Med. 2004 Sep 21;141(6):475-6
references.pmid: 15381522
references.citation: Circulation. 2009 Jan 20;119(2):351-7
references.pmid: 19095622
references.citation: JAMA. 2007 Aug 15;298(7):765-75
references.pmid: 17699010
references.citation: Curr Heart Fail Rep. 2005 Aug;2(2):94-9
references.pmid: 16036057
references.citation: Lancet. 2000 Mar 4;355(9206):773-8
references.pmid: 10711923
references.citation: Am Heart J. 2005 Jun;149(6):984-93
references.pmid: 15976779
references.citation: N Engl J Med. 2001 Nov 8;345(19):1359-67
references.pmid: 11794168
references.citation: J Am Coll Cardiol. 2001 Nov 1;38(5):1440-9
references.pmid: 11691521
references.citation: JAMA. 2004 Jan 21;291(3):335-42
references.pmid: 14734596
references.citation: N Engl J Med. 1998 Jul 23;339(4):229-34
references.pmid: 9673301
references.citation: Lancet. 1998 Sep 12;352(9131):854-65
references.pmid: 9742977
references.citation: Am J Cardiol. 2005 Aug 1;96(3):363-5
references.pmid: 16054458
references.citation: Lancet. 2002 Jun 22;359(9324):2140-4
references.pmid: 12090978
references.citation: Circulation. 2002 Nov 19;106(21):2652-8
references.pmid: 12438289
references.citation: Am J Cardiol. 2005 Sep 1;96(5):611-6
references.pmid: 16125480
references.citation: Ital Heart J Suppl. 2000 Jul;1(7):951-2
references.pmid: 10935745
references.citation: J Am Coll Cardiol. 1995 Jul;26(1):57-65
references.pmid: 7797776
references.citation: Circulation. 2005 Jun 14;111(23):3078-86
references.pmid: 15939812